Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Leading Genomic Scientists Reveal the Role of Non-Coding RNA Molecules in Disease Development

The Academy will host a cancer research symposium on November 16.

Published October 29, 2010

Cancer research has revealed that complex systems of molecular pathways drive tumor formation. By understanding these pathways, scientists hope to identify molecular targets within them that would be receptive to drugs in ways that could interrupt cancer progression. Non-coding RNAs—RNA molecules that do not encode for proteins—are emerging as important regulators of development and function in many physiological processes. At a November 16 symposium at the New York Academy of Sciences, five of the nation’s leading genomics and pathology researchers will assess the role of non-coding RNAs in controlling disease development and their potential as targets for therapeutic intervention.

WHAT: A Scientific Symposium: Non-Coding RNAs in Oncogenesis

WHO: Speakers:
Greg Hannon, PhD, Cold Spring Harbor Laboratory
Pier Paolo Pandolfi, MD, PhD, Harvard Medical School
John Rinn, PhD, Harvard Medical School
Ramin Shiekhattar, PhD, The Wistar Institute
David Spector, PhD, Cold Spring Harbor Laboratory

WHEN: Tuesday, November 16, 2010 | 1:00 pm – 5:00 pm

WHERE: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY

This symposium is presented by the New York Academy of Sciences' Cancer & Signaling Discussion Group, and is part of the Academy’s Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation.. For more information see

Media must register in advance by contacting Adrienne Burke, Director, Public Outreach, the New York Academy of Sciences, at, 212.298.8655.

The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Visit us online at